Insider trade

Officer sold ~$600K of CRL shares in the open market

Traded Aug 19, 2026 · Filed Aug 20, 2026

~$600K
Approx. value · 2,039 sh @ $294.12: 4,807
Holds after · shares reported: +7.2%
stock since the trade · S&P 500 +0.8%, $290.00 → $310.77 on Oct 5

Why it stands out

Charles River Laboratories's CEVP, Disc & Safety Assessment sold $600K of Charles River Laboratories shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 19, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 20, 2026

Officer$500K–$1MPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$599,711

Shares × reported transaction price

Timing vs results

14 days after results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $290.00 on Aug 19, 2026, at its 52-week high, after a 29% rise over the previous 30 trading days

52-week range $145.57 (Sep 25, 2025) to $290.00 (Aug 19, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $223.96 on Jul 8, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred